Tradestie Institutional Equity Comparison Engine

AIMD vs RENX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AIMD Overall Edge

AIMD Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ainos, Inc. Common Stock (AIMD) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, AIMD trades at 13.9x Forward P/E with -101210.2% operating margin (-96.7% YoY revenue) versus RENX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AIMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RENX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AIMD
AIMD 13.9x vs RENX N/M Fwd P/E
Growth & Margin Winner AIMD
Op Margin -101210.2% vs N/A ยท YoY -96.7% vs N/A
Momentum & Technical Winner AIMD
1Y -41.6% vs +163.6% ยท 52W Pos 22% vs 19%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AIMD NASDAQ
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap $8.4M
1M Return +39.79%
1Y Return -41.58%
Forward P/E 13.9x
Unified AI Score
23.4 / 100 STRONG SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 44.0
RENX US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap N/A
1M Return -48.21%
1Y Return +163.59%
Forward P/E N/M
Unified AI Score
44.0 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AIMD -41.58% RENX +163.59% Spread: +207.66 pp (RENX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AIMD TTM Op. Margin: -101210.2% RENX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AIMD vs RENX. Trailing 12-month operating profitability (AIMD -101210.2% vs RENX N/A) and valuation multiples (AIMD 13.9x vs RENX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AIMD (8) vs RENX (2)
Institutional Metric AIMD RENX Criterion Row Winner
Market Capitalization Scale $8.4M N/A Larger Scale AIMD
Trailing P/E Ratio Valuation 13.9x N/M Lower Multiple AIMD
Forward P/E Ratio Valuation 13.9x N/M Lower Multiple AIMD
Revenue Growth (YoY) Growth -96.7% N/A Higher Growth AIMD
Operating Margin (TTM) Profitability -101210.2% N/A Higher Margin AIMD
Net Profit Margin Profitability 0.0% N/A Higher Margin AIMD
Return on Equity (ROE) Capital Efficiency -196.3% N/A Higher ROE AIMD
52-Week Range Position Momentum 22% ($0โ€“$4) 19% ($0โ€“$3) Stronger Trend AIMD
Beta / 30D Volatility Risk Regime 2.03ฮฒ ยท 437% Vol -17.85ฮฒ ยท 161% Vol Lower Realized Risk RENX
Unified Institutional Score Composite Signal 23.4 / 100 (STRONG SELL) 44.0 / 100 (HOLD) Higher Composite RENX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AIMD vs RENX Buy Guide
AIMD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AIMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RENX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RENX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AIMD nor RENX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.